Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SMMT
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Summit Therapeutics Inc (SMMT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Summit Therapeutics (SMMT) trades at $13.35, down 4.64% today, with a neutral technical outlook despite bearish moving averages. The company shows significant financial strain with negative ROE of -192.5% and net loss of $1.08B in 2025, though cash flow remains positive through financing activities. Recent developments include FDA review of ivonescimab with a November 2026 decision date and new clinical collaborations expanding the drug's development pipeline.
The investment case hinges on ivonescimab's regulatory approval potential, with analyst consensus target of $24.18 offering 81% upside. However, substantial execution risks exist including cash burn, ongoing losses, and fiduciary duty investigations. The stock presents high-risk speculation on binary regulatory outcomes rather than current fundamentals.
Read full analysis

Key Stats

  • Market Cap
    $10.65B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $26.98
  • 52W Low
    $12.55
  • Typical Hold Time
    -
  • Enterprise Value
    $9.98B
  • Div Yield
    -
  • Trading Activity
    -
$13.3
52W Low: $12.55
28 Jul 2026
52W High: $26.98
26 Aug 2025

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.55 and a high of $26.98, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Most Recent News

Content is generated by Aura AI

Ferrari's first electric car sells for $40M at auction, setting a new record for a new car sale.

Ferrari's first all-electric car, the Luce, sold for $40 million at a charity auction during Monterey Car Week, far exceeding its $1.1 million estimate. This sale set a new record for the highest price paid for a new car at auction, with proceeds goi...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
pluang ai news

Rocket Lab launches eight satellites to replenish Globalstar's communications network under $143M contract.

Rocket Lab successfully launched eight customized Lightning satellites on August 15 from Cape Canaveral to replenish Globalstar's communications constellation. These satellites, part of a $143 million contract with MDA Space, will enhance Globalstar'...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
pluang ai news

Law firm probes iRhythm officers for possible breach of duties to shareholders

Halper Sadeh LLC is investigating whether officers and directors of iRhythm Technologies breached their fiduciary duties to shareholders. Long-term iRhythm stockholders may seek reforms, financial incentives, or other relief if misconduct is found. T...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $10.65B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $26.98
  • 52W Low
    $12.55
  • Typical Hold Time
    -
  • Enterprise Value
    $9.98B
  • Div Yield
    -
  • Trading Activity
    -
$13.3
52W Low: $12.55
28 Jul 2026
52W High: $26.98
26 Aug 2025

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.55 and a high of $26.98, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!